blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3682022

EP3682022 - HUMAN THERAPEUTIC TARGETS AND MODULATORS THEREOF [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  13.09.2024
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  19.06.2020
FormerThe international publication has been made
Status updated on  22.03.2019
Most recent event   Tooltip17.09.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
LifeMine Therapeutics, Inc.
30 Acorn Park Drive
Cambridge, MA 02140 / US
[2024/35]
Former [2020/30]For all designated states
Lifemine Therapeutics, Inc.
30 Acorn Park Drive
Cambridge, Massachusetts 02140 / US
Inventor(s)01 / BIGGINS, John Baxter
c/o LIFEMINE THERAPEUTICS, INC.
30 Acorn Park Drive
Cambridge Massachusetts 02140 / US
02 / BOWMAN, Brian Roger
c/o LIFEMINE THERAPEUTICS, INC.
30 Acorn Park Drive
Cambridge Massachusetts 02140 / US
03 / VERDINE, Gregory L.
c/o LIFEMINE THERAPEUTICS, INC.
30 Acorn Park Drive
Cambridge, Massachusetts 02140 / US
 [2020/30]
Representative(s)Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Ganghoferstraße 68 B
80339 München / DE
[2020/30]
Application number, filing date18855399.414.09.2018
[2020/30]
WO2018US51134
Priority number, dateUS201762558744P14.09.2017         Original published format: US 201762558744 P
[2020/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019055816
Date:21.03.2019
Language:EN
[2019/12]
Type: A1 Application with search report 
No.:EP3682022
Date:22.07.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 21.03.2019 takes the place of the publication of the European patent application.
[2020/30]
Search report(s)International search report - published on:US21.03.2019
(Supplementary) European search report - dispatched on:EP11.05.2021
ClassificationIPC:G16B10/00, G16B30/10, C12Q1/68, C12Q1/6895, C12N9/02, C12N9/58, C12N15/52
[2021/23]
CPC:
G16B10/00 (EP); G16B20/00 (US); G16B30/10 (EP);
G16B35/10 (US)
Former IPC [2020/30]C12Q1/68, C12Q1/6895, C12N9/02, C12N9/58, C12N15/52
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/30]
TitleGerman:MENSCHLICHE THERAPEUTISCHE ZIELMOLEKÜLE UND MODULATOREN DAVON[2020/30]
English:HUMAN THERAPEUTIC TARGETS AND MODULATORS THEREOF[2020/30]
French:CIBLES THÉRAPEUTIQUES HUMAINES ET MODULATEURS ASSOCIÉS[2020/30]
Entry into regional phase14.04.2020National basic fee paid 
14.04.2020Search fee paid 
14.04.2020Designation fee(s) paid 
14.04.2020Examination fee paid 
Examination procedure14.04.2020Examination requested  [2020/30]
13.01.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
23.03.2022Amendment by applicant (claims and/or description)
16.09.2024Despatch of a communication from the examining division (Time limit: M04)
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
23.03.2022Request for further processing filed
23.03.2022Full payment received (date of receipt of payment)
Request granted
07.04.2022Decision despatched
Fees paidRenewal fee
24.09.2020Renewal fee patent year 03
27.09.2021Renewal fee patent year 04
29.09.2022Renewal fee patent year 05
24.08.2023Renewal fee patent year 06
12.09.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US2004076981  (YODER OLEN [US], et al);
 [A]US2006205017  (HANDELSMAN JO [US], et al);
 [A]US8065089  (NAJARIAN KAYVAN [US]);
 [A]WO2014071182  (MASSACHUSETTS INST TECHNOLOGY [US]);
 [X]WO2017100917  (UNIV MCMASTER [CA]);
 [PX]WO2018094110  (UNIV LELAND STANFORD JUNIOR [US]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.